Skip to main content
BioLineRx Ltd. logo

BioLineRx Ltd. — Investor Relations & Filings

Ticker · BLRX ISIN · US09071M2052 LEI · 529900AKIOSC15Y63R18 TA Manufacturing
Open in API
Filings indexed 1,676 across all filing types
Latest filing 2022-05-11 Interim / Quarterly Rep…
Country IL Israel
Listing TA BLRX

About BioLineRx Ltd.

https://www.biolinerx.com/

BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and rare diseases. The company leverages its drug development capabilities to advance novel, early-stage therapeutic candidates through the clinical development process toward regulatory approval. Its pipeline consists of treatments, including small molecules, designed to address unmet medical needs and deliver meaningful benefits to patients. BioLineRx also partners with other drug developers to advance their early-stage programs.

Recent filings

Filing Released Lang Actions
FORM 6-K-Reports First Quarter 2022 Financial Results
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed with the SEC by BioLineRx Ltd. It contains the company's quarterly financial results, including condensed consolidated interim financial statements and an operating and financial review for the period ended March 31, 2022. Because it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2022
2022-05-11 English
FORM 6-K-Reports First Quarter 2022 Financial Results
Earnings Release Classification · 98% confidence The document explicitly states, "BioLineRx Reports First Quarter 2022 Financial Results and Provides Corporate Update" and immediately follows this with the statement, "Attached hereto is a report on *BioLineRx Reports First Quarter 2022 Financial Results and Provides Corporate Update* *6K_11-May-2022_isa.pdf*". This structure indicates that the current document is an announcement about the release of the actual financial results report (which is attached as a PDF), rather than the comprehensive report itself. Since it is announcing the release of periodical financial results, it aligns best with the Earnings Release (ER) definition, which covers initial announcements of periodical financial results. However, given the explicit mention of an attachment and the short length (1899 chars), the 'Menu vs Meal' rule suggests classifying it as a Report Publication Announcement (RPA) because it is primarily announcing the publication of the detailed results (the 6K PDF). Since the content is about quarterly financial results, ER is also a strong candidate, but RPA captures the nature of this specific filing (an announcement wrapper). Given the context of reporting financial results for a period shorter than a year ('First Quarter 2022'), the Interim/Quarterly Report (IR) is the comprehensive document being referenced. This filing acts as the notification wrapper for that IR/ER. Because it is announcing the release of the quarterly results, and it is a regulatory filing wrapper, RPA is the most precise fit for the wrapper document itself, though ER is the subject matter. I will select RPA based on the 'Menu vs Meal' rule, as it is an announcement of publication. Q1 2022
2022-05-11 English
20-F
Annual Report FY 2021
2022-03-16 English
Form 20-F 2021
Annual Report Classification · 100% confidence The document is explicitly titled 'FORM 20-F' and identified as an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934'. It includes a comprehensive table of contents covering business operations, financial statements, and management discussion, which is characteristic of a 10-K equivalent for foreign private issuers (Form 20-F). FY 2021
2022-03-16 English
Form 20-F 2021
Report Publication Announcement Classification · 98% confidence The document explicitly states it is an 'Immediate Report' under Israeli regulations, and the core content is: 'Attached hereto is a report on *Annual Report on Form 20-F* *Form_20-F_Year_2021_isa.pdf*'. A Form 20-F is the annual report filed by foreign private issuers with the SEC, equivalent in function to a 10-K for domestic issuers. However, the document itself is not the 20-F; it is a short announcement (1790 chars) stating that the 20-F is attached or published. According to Rule 2 ('MENU VS MEAL' Rule), when a document announces the publication of a report rather than containing the full report, it should be classified as a Report Publication Announcement (RPA). Although the content relates to an Annual Report (10-K equivalent), the document's nature is the announcement itself.
2022-03-16 English
BioLineRx Reports Fourth Quarter 2021 Financial Results and Provides Corporate Update
Earnings Release Classification · 98% confidence The document explicitly states it is a "FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934" for the month of March 2022. Form 6-K filings are used by foreign private issuers to report material information to the SEC, often including press releases about financial results. The content is a press release titled "BioLineRx Reports Fourth Quarter 2021 Financial Results and Provides Corporate Update," which details financial performance for the year ended December 31, 2021, and includes a conference call announcement. This structure—a Form 6-K containing an earnings press release—is most closely aligned with an Earnings Release (ER) or, given the comprehensive nature of the financial review, potentially an Interim/Quarterly Report (IR) if it were a 10-Q equivalent. However, since the primary content is the announcement of the quarterly/annual financial results (highlights and management discussion) and it is filed on Form 6-K (a general reporting mechanism for foreign issuers), the best fit among the provided codes is the Earnings Release (ER), as it is the initial announcement of period results. It is not a full 10-K, nor is it just a simple announcement of a report publication (RPA). Q4 2021
2022-03-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.